Brief: Inhibikase Therapeutics Announces Retirement of CFO Joseph Frattaroli
16/01/2024 21:41
Jan 16 (Reuters) - Inhibikase Therapeutics Inc IKT.O :
* INHIBIKASE THERAPEUTICS ANNOUNCES PLANNED RETIREMENT OF
CHIEF
FINANCIAL OFFICER JOSEPH FRATTAROLI
* INHIBIKASE THERAPEUTICS INC - COMPANY'S VICE-PRESIDENT FOR
FINANCE, GARTH LEES-ROLFE, WILL BE PROMOTED TO CHIEF FINANCIAL
OFFICER
Source text for Eikon: ID:nGNX1sNBh6
Further company coverage: IKT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inhibikase Therapeutics
See all newsBrief: Inhibikase Therapeutics Prices Public Offering Of 46 Million Shares At $1.45 Per Share
Brief: Inhibikase Therapeutics Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
Brief: Inhibikase Therapeutics Advancing IKT-001 To Global Phase 3 Study In Pulmonary Arterial Hypertension
Cardiopulmonary drugmaker Inhibikase Therapeutics' Q3 net loss widens
Inhibikase Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary